The semaglutide versus tirzepatide comparison page outlines the differences between the two main GLP-1 compounds, while the decision between drops and injections comes down to individual physiology and lifestyle preferences
doi: 10.1186/s12933-022-01474-z Summary Keywords glucagon-like peptide-1, glucagon-like peptide-1 receptor agonist, cardiovascular diseases, major adverse cardiovascular events, diabetes mellitus Citation Ferhatbegovi L, Mri D and Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases
GLP-1 drugs work to counteract insulin resistance by increasing insulin sensitivity in neurons
Plusieurs techniques Depuis quelques annes, de nouvelles techniques font leur apparition sur le march pour rpondre cette demande grandissante
The Negative Effects and Benefits of Plant-Based Diets What are the pros and cons of plant-based eating
Lung cancer risk in never-smokers of European descent is associated with genetic variation in the 5(p)15.33 TERT-CLPTM1Ll region